1. ALK Non-Small Cell Lung Cancer Industry Assessment 2017-2030
- Subjects
Brigatinib -- Forecasts and trends -- Reports ,BCG -- Forecasts and trends -- Reports ,Crizotinib -- Reports -- Forecasts and trends ,Ceritinib -- Forecasts and trends -- Reports ,Small cell lung cancer -- Forecasts and trends -- Reports ,Epidemiology -- Reports -- Forecasts and trends ,Lymphomas -- Reports -- Forecasts and trends ,Non-small cell lung cancer -- Reports -- Forecasts and trends ,Alectinib -- Forecasts and trends -- Reports ,Market trend/market analysis ,Business, international ,Law - Abstract
(GlobeNewswire) - The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]
- Published
- 2020